Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
Lomefloxacin
Lomefloxacine · LFLX · dm-10 · Clfimono · SC 47111A · Lomel9act · LOMEFLOXACIN · LEMOFLOXACIN
식별자 및 물리적 특성
| CAS No. | 98079-51-7 |
|---|---|
| 분자식 | C17H19F2N3O3 |
| 평균 분자량 | 351.35 g/mol |
| 단동위원소 질량 | 351.13944791 g/mol |
| SMILES | CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNC(C)C3)c(F)c21 |
| InChIKey | ZEKZLJVOYLTDKK-UHFFFAOYSA-N |
| PubChem CID | 3948 |
| ChEMBL | CHEMBL561 |
| ChEBI | CHEBI:116278 |
| EC No. | 619-317-6 |
| DTXSID | DTXSID4040680 |
화학 및 물리적 성질
| XLogP | -0.8 |
|---|---|
| 극성 표면적 | 72.9 |
| 수소 결합 공여자 수 | 2 |
| 수소 결합 수용자 수 | 8 |
| 회전 가능 결합 수 | 3 |
| 무거운 원자 수 | 25 |
| 형식 전하 | 0 |
| 복잡도 | 585 |
| 의약품 | Pharmaceuticals -> AntibioticsPharmaceuticals -> Anti infectives for systemic use -> Antibacterials for systemic use |
| LogP(분배 계수) | 2.8 |
| 용해도 | 1.06e-01 g/LDMSO (약간 용해됨), 메탄올(약간 용해됨,가열, 초음파 처리) |
| Human Drugs | Breast FeedingLactationMilk, HumanAnti-Infective AgentsAntibacterial AgentsQuinolonesFluoroquinolones |
| 녹는점 | 239-240.5 °C239 - 240.5 °C239-240 C |
| Physical Description | Solid |
| Dissociation Constants | 5.742 |
| Collision Cross Section | 191.3 Ų [M+H]+ [CCS Type: TWMethod: calibrated with Waters Major Mix]191.04 Ų [M+K]+ [CCS Type: TWMethod: calibrated with polyalanine and drug standards] |
| 끓는 점 | 542.7±50.0 °C(Predicted) |
| 밀도 | 1.342±0.06 g/cm3(Predicted) |
| 저장 조건 | Keep in dark place,Sealed in dry,Store in freezer, under -20°C |
| 물리적 상태 | 고체 |
| pKa(산도 계수) | -0.25±0.20(Predicted) |
| 색상 | 연한 노란색에서 밝은 노란색까지 |
| EPA | 3-Quinolinecarboxylic acid, 1-ethyl-6,8-difluoro-1,4-dihydro-7-(3-methyl-1-piperazinyl)-4-oxo- (98079-51-7) |
화학적 성질
colorless Needles
안전 및 규제
| GHS 분류 | WarningH302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]P261, P264, P270, P271, P280, P301+P317, P302+P352, P304+P340, P317, P321, P330, P362+P364, and P501 (click each P-code to see the statement)The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory. |
|---|---|
| 규제 정보 | Status: Active Update: 17-03-2017 https://echa.europa.eu/registration-dossier/-/registered-dossier/19305 |
| Hazard Classes and Categories | Acute Tox. 4 (100%) |
| Drug Induced Liver Injury | Drug-Induced Liver Injury Severity and Toxicity (DILIst)lomefloxacinDILI NegativeOralDOI:10.1016/j.drudis.2019.09.022 |
| Effects During Pregnancy and Lactation | ◉ Summary of Use during Lactation |
| 수질 위해 등급(WGK) | 3 |
| RTECS 번호 | VB1997500 |
| 독성 | LD50 in mice (mg/kg): 245.6 i.v.>4000 orally (Itoh) |
| 관세 코드 | 29419000 |
| 위험 문구(R) | 22-36/37/38 |
| 위험 표시 | Xn,Xi |
| 안전 문구(S) | 26-36 |
용도
개요
Lomefloxacin is a once-daily, third-generation quinolone antibiotic useful in the treatment of bacterial infections. The new fluorinated quinolone does not interfere with the metabolism of theophylline; it is efficacious against pathogens resistant to cephalosporins, penicillins and aminoglycosides.
용도
Anti bacterial.